GALECTIN THERAPEUTICS INC - COM NEW (GALT)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024: Q1 2024
Type / Class: Equity / COM NEW
Shares, excl. options Q1 2024: 7.4 M
Holdings value Q1 2024: $17.7 M
Value change Q1 2024: +$1.17 M
Grand Portfolio weight change Q1 2024: +0%
Number of holders: 55
Number of buys Q1 2024: 19
Number of sells Q1 2024: -18
Average buys Q1 2024 %: +0%
Average sells Q1 2024 %: 0%
CUSIP: 363225202

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	7.4 M	$17.7 M	+$1.17 M	0	146 K	$2.39	56
2023 Q4	7.01 M	$11.6 M	-$3.13 M	7.3 K	29.4 K	$1.66	63
2023 Q3	9.02 M	$17.3 M	+$3.46 M	0	29 K	$1.92	57
2023 Q2	7.25 M	$10.4 M	+$114 K	3.46 K	68.8 K	$1.44	56
2023 Q1	7.15 M	$15 M	+$220 K	6.93 K	148 K	$2.10	55
2022 Q4	5.82 M	$6.57 M	+$182 K	32 K	76.8 K	$1.13	55
2022 Q3	5.62 M	$9.16 M	-$200 K	120 K	287 K	$1.63	50
2022 Q2	4.99 M	$6.53 M	-$575 K	94 K	158 K	$1.31	51
2022 Q1	6.19 M	$9.95 M	-$322 K	204 K	355 K	$1.61	51
2021 Q4	7.32 M	$15.1 M	-$497 K	299 K	548 K	$2.07	51
2021 Q3	7.19 M	$27.9 M	-$2.18 M	1.02 M	1.65 M	$3.88	65
2021 Q2	6.51 M	$20.8 M	-$5 M	609 K	578 K	$3.20	69
2021 Q1	9.38 M	$20.4 M	-$1.72 M	220 K	103 K	$2.17	67
2020 Q4	10.2 M	$22.8 M	+$478 K	293 K	278 K	$2.24	70
2020 Q3	9.97 M	$26.6 M	-$295 K	183 K	403 K	$2.67	64
2020 Q2	8.21 M	$25.1 M	+$906 K	179 K	240 K	$3.06	69
2020 Q1	8.8 M	$17.2 M	-$1.08 M	154 K	208 K	$1.96	70
2019 Q4	10 M	$28.7 M	+$1.84 M	736 K	258 K	$2.86	73
2019 Q3	9.37 M	$34.4 M	+$3.09 M	994 K	421 K	$3.67	73
2019 Q2	8.48 M	$35.2 M	+$4.36 M	1.25 M	685 K	$4.15	72
2019 Q1	6.61 M	$33.8 M	+$9.06 M	2.23 M	1.36 M	$5.11	61
2018 Q4	5.06 M	$17.4 M	-$2.42 M	1.84 M	1.1 M	$3.43	56
2018 Q3	6.01 M	$35.8 M	+$1.92 M	2.83 M	1.88 M	$6.01	59
2018 Q2	5.57 M	$35.5 M	+$4.18 M	2.67 M	568 K	$6.36	66
2018 Q1	4.96 M	$23.5 M	+$6.15 M	663 K	513 K	$4.74	56
2017 Q4	3.73 M	$12.5 M	-$433 K	179 K	298 K	$3.34	45
2017 Q3	3.78 M	$8.07 M	+$14.3 K	289 K	218 K	$2.13	43
2017 Q2	3.97 M	$9.77 M	+$859 K	248 K	410 K	$2.46	45
2017 Q1	3.53 M	$8.13 M	+$1.93 M	45 K	216 K	$2.30	37
2016 Q4	2.84 M	$2.78 M	-$227 K	0	81 K	$0.98	35
2016 Q3	3.02 M	$3.42 M	-$601 K	52 K	124 K	$1.13	39
2016 Q2	3.49 M	$5.12 M	-$570 K	17 K	32 K	$1.47	42
2016 Q1	3.47 M	$4.96 M	-$243 K	41 K	730 K	$1.43	38
2015 Q4	3.55 M	$5.81 M	+$1.25 M	73 K	819 K	$1.64	44
2015 Q3	2.58 M	$6.03 M	-$1.4 M	78 K	4 K	$2.34	38
2015 Q2	3.14 M	$8.56 M	-$2.04 M	209 K	3 K	$2.73	50
2015 Q1	4.05 M	$13.6 M	+$949 K	171 K	76 K	$3.35	55
2014 Q4	3.75 M	$13 M	-$3.08 M	569 K	12 K	$3.47	57
2014 Q3	4.28 M	$21.5 M	-$4.78 M	1.08 M	261 K	$5.03	60
2014 Q2	4.24 M	$58.6 M	+$9.16 M	3.36 M	1.6 M	$13.81	62
2014 Q1	3.47 M	$53.1 M	+$31.9 M	8.41 M	2.77 M	$15.31	49